 Connection
Co-Authors
This is a "connection" page, showing publications co-authored by Samer Al Hadidi and Asis Shrestha.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.380 |
|
|
|
-
Shrestha A, Alzubi M, Alrawabdeh J, Schinke C, Thanendrarajan S, Zangari M, van Rhee F, Al Hadidi S. B-cell maturation antigen-based therapies post-talquetamab in relapsed or refractory multiple myeloma. EJHaem. 2024 Jun; 5(3):554-559.
Score: 0.901
-
Shrestha A, Thanendrarajan S, Bag A, Dhakal B, Zangari M, Al-Hadidi S, van Rhee F, D'Souza A, Shah N, Shah MR, Mohan M, Schinke C. The efficacy of teclistamab in patients with multiple myeloma and secondary plasma cell leukemia. Blood Adv. 2025 Oct 14; 9(19):4806-4809.
Score: 0.250
-
Naqvi S, Shrestha A, Alzubi M, Alrawabdeh J, Thanendrarajan S, Zangari M, van Rhee F, Schinke C, Al Hadidi S. Weight loss and dysgeusia in relapsed/refractory multiple myeloma patients treated with talquetamab. EJHaem. 2024 Aug; 5(4):789-792.
Score: 0.229
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|